Mengdie Yuan

Cure Frailty Models

Mengdie Yuan, Xiangmin Zhang, G. Diao, 2017 .

Semiparametric Odds Rate Model for Modeling Short-Term and Long-Term Effects with Application to a Breast Cancer Genetic Study

Mengdie Yuan, G. Diao, 2014, The international journal of biostatistics.

Sieve maximum likelihood estimation in generalized linear models with an unknown link function

Mengdie Yuan, G. Diao, 2018 .

Comparing the Response Rates for Superiority, Noninferiority and Equivalence Testing with Multiple-to-One Matched Binary Data

Mengdie Yuan, M. Shen, Xiaoyu Dong, 2013, Journal of biopharmaceutical statistics.

FDA Approval Summary: Nivolumab plus ipilimumab for the treatment of patients with hepatocellular carcinoma previously treated with sorafenib.

L. Fashoyin-Aje, Martha Donoghue, K. Goldberg, 2021, The oncologist.

Interchangeability: Generic Drugs

Shein-Chung Chow, Jiayin Zheng, Mengdie Yuan, 2018 .

On assessing bioequivalence and interchangeability between generics based on indirect comparisons

S. Chow, Mengdie Yuan, Jiayin Zheng, 2017, Statistics in medicine.

FDA Approval Summary: Pembrolizumab for the Treatment of Tumor Mutational Burden–High Solid Tumors

Reena Philip, L. Fashoyin-Aje, Martha Donoghue, 2021, Clinical Cancer Research.